Cited by 105Cardiac Arrhythmias and TreatmentsAtrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients

Open access
Clair, W K, Wilkinson, W E, McCarthy, E A, Page, R L, Pritchett, E L·1993·Circulation

Abstract

BACKGROUND: Ambulatory outpatients (n = 150) with a history of paroxysmal supraventricular arrhythmia were studied to establish the characteristics of the first recurrence of symptomatic tachycardia (time to first recurrence, heart rate during tachycardia, and observed rhythm that was regular versus irregular) when no antiarrhythmic drug was being taken. Baseline variables were examined to assess their impact on time to first recurrence: index arrhythmia (paroxysmal atrial fibrillation [n = 37] versus paroxysmal supraventricular tachycardia [n = 113]), age (mean +/- SD, 43.3 +/- 16.1 years), female sex (n = 71), or presence of other heart or lung disease (n = 53). METHODS AND RESULTS: Transtelephonic monitoring of the ECG was used to document the rhythm during recurrences of symptomatic tachycardia. Time to first recurrence of symptomatic tachycardia and heart rate during tachycardia were measured, the observed rhythm was classified as irregular (consistent with paroxysmal atrial fibrillation) or regular (consistent with paroxysmal supraventricular tachycardia), and the hour of recurrence was recorded. Advancing age was significantly associated with a decreasing time to first recurrence (p < 0.001); the estimated increase in the hazard function was 25% with each 10 years of advancing age. After the effect of age was adjusted for, neither the classification of arrhythmia (p > 0.2), presence of other heart or lung disease (p > 0.8), nor sex (p > 0.9) was significantly associated with time to first recurrence. Among patients with paroxysmal supraventricular tachycardia, 6.5% had atrial fibrillation recorded at the next symptomatic arrhythmia; among patients with paroxysmal atrial fibrillation, 11.8% had a regular tachycardia recorded at the next symptomatic arrhythmia. There was a circadian pattern to the hour of occurrence of paroxysmal supraventricular tachycardia but not paroxysmal atrial fibrillation. CONCLUSIONS: Age is more important than other clinical variables, including the ECG classification of a paroxysmal supraventricular arrhythmia in predicting the occurrence of symptomatic arrhythmias. Arrhythmias documented by ECG during symptoms are often different from the arrhythmia documented at the time of referral, which may confound interpretation of antiarrhythmic drug effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.87.4.1114

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 12 · Cited by 105

Research works printed but not linked: 9

  1. Irwin JM, McCarthy EA, Wilkinson WE, Pritchett ELC: Circadian occurrence of symptomatic paroxysmal supraventricular tachycar- dia in untreated patients. Circulation 1988;77:298-300
  2. Kalbfleish JD, Prentice RL: The Statistical Analysis ofFailure Time Data. New York, John Wiley & Sons, Inc, 1980
  3. Pritchett ELC, Smith MS, McCarthy EA, Kerry LL: The sponta- neous occurrence of paroxysmal supraventricular tachycardia. Cir- culation 1984;70:1-6
  4. Fleiss JL: Statistical Methods for Rates and Proportions. New York, John Wiley & Sons, Inc, 1981
  5. Yee R, Klein GJ, Sharma AD, Fujimura 0, Boahene KA: Tachy- cardia associated with accessory atrioventricular pathways, in Zipes DP, Jalife J (eds): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa, WB Saunders Co, 1990, pp 463-472
  6. Bauernfeind RA, Wyndham CR, Swiryn SP, Palileo EV, Strasberg B, Lam W, Westveer D, Rosen KM: Atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol 1981;47:562-569
  7. Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Bhandari AK, Hawkinson RW, Pritchett ELC, the Flecainide Supraventricular Tachycardia Study Group: Prevention of symp- tomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy: A multicenter, double- blind, placebo-controlled, crossover study of flecainide and pla- cebo using transtelephonic monitoring. Circulation 1989;80: 1557-1570
  8. Clair WK, Wilkinson WE, McCarthy EA, Pritchett ELC: Treat- ment of paroxysmal supraventricular tachycardia with oral diltia- zem. Clin Pharmacol Ther 1992;51:562-565
  9. Pritchett ELC, McCarthy EA, Wilkinson WE: Propafanone treat- ment of symptomatic paroxysmal supraventricular arrhythmias: A randomized, placebo-controlled, crossover trial in patients tolerat- ing oral therapy. Ann Intern Med 1991;114:539-544

Authors
Clair, W. K., Wilkinson, W. E., McCarthy, E. A., Page, R. L., & Pritchett, E. L.
Affiliations
Duke Medical Center (US)
Venue
Circulation
Published
1993-04
Volume
87
Issue
4
Pages
1114-1122
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2090345770
Cited by
105
References
12
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2022: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 5 · 2013: 3 · 2012: 6
FWCI
2.96
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1r01hl040392-01a1)
  • National Heart, Lung, and Blood Institute (R01-HL-40392)
  • National Center for Research Resources (MO 1 RR-30)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
paroxysmal supraventricular tachycardia, arrhythmia recurrence, untreated patients, age as risk factor, arrhythmia classification, sex differences, time to recurrence
MeSH terms
Adult, Age Factors, Atrial Fibrillation, Electrocardiography, Female, Humans, Male, Middle Aged, Recurrence, Tachycardia, Paroxysmal, Tachycardia, Supraventricular, Telephone, Time Factors, Wolff-Parkinson-White Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review